Folic acid is not recommended because of the potentially low activity of dihydrofolate reductase in cerebral folate deficiency, and because of its tight binding to folate receptor alpha that results in reduced cerebral transport of 5-methyltetrahydrofolate. The gene discussed is FOLR1; the disease is folate deficiency.